Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
276 SEK | -0.14% | +2.00% | +3.37% |
19/06 | Sobi Wins EU Approval for Hemophilia A Drug Altuvoct | MT |
19/06 | European Commission Grants Sobi® Marketing Authorisation for Altuvoct? for Treatment of Haemophilia A | CI |
- Stock Market
- Equities
- SOBI Stock
- News Swedish Orphan Biovitrum AB